35 Works
Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang & Jinxi Zhao
Abstract Objective To evaluate the cardiovascular and renal benefits of finerenone, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagonlike peptide-1 receptor agonists (GLP-1 RA) in patients with Type 2 Diabetes Mellitus (T2DM) and chronic kidney disease (CKD) with network meta-analysis. Methods Systematic literature searches were conducted of PubMed, Cochrane Library, Web of Science, Medline and Embase covering January 1, 2000 to December 30, 2021. Randomized control trials (RCTs) comparing finerenone, SGLT-2i and GLP-1 RA in diabetics with...
NCALD as a potential predictive biomarkerfor the efficacy of platinum-basedchemotherapy in ovarian cancer - Supplementary Figure 3
Sarah M Konrad, Kristina Schwamborn, Achim Kru¨ ger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill & Juliane Ramser
Aim: Since reliable response predictors to platinum-based chemotherapy in ovarian cancer (OC) are scarce, we characterize NCALD as a predictive biomarker. Materials & methods: NCALD mRNA (n = 100) and protein (n = 102) expression was analyzed in OC samples and associated with patient outcome. A stable OC cell line knockdown was generated and cellular response to platinum was explored. Results: High NCALD mRNA and protein expression was significantly associated with longer overall patient survival...
NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer - Supplementary Figure 2
Sarah M Konrad, Kristina Schwamborn, Achim Kru¨ ger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill & Juliane Ramser
Aim: Since reliable response predictors to platinum-based chemotherapy in ovarian cancer (OC) are scarce, we characterize NCALD as a predictive biomarker. Materials & methods: NCALD mRNA (n = 100) and protein (n = 102) expression was analyzed in OC samples and associated with patient outcome. A stable OC cell line knockdown was generated and cellular response to platinum was explored. Results: High NCALD mRNA and protein expression was significantly associated with longer overall patient survival...
NCALD as a potential predictive biomarker for the efficacy of platinum-based - Supplementary Table 1
Sarah M Konrad, Kristina Schwamborn, Achim Kru¨ ger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill & Juliane Ramser
Aim: Since reliable response predictors to platinum-based chemotherapy in ovarian cancer (OC) are scarce, we characterize NCALD as a predictive biomarker. Materials & methods: NCALD mRNA (n = 100) and protein (n = 102) expression was analyzed in OC samples and associated with patient outcome. A stable OC cell line knockdown was generated and cellular response to platinum was explored. Results: High NCALD mRNA and protein expression was significantly associated with longer overall patient survival...
Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial design
Beatriz Olaya, Christina M. Van der Feltz-Cornelis, Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Marjo Sinokki, Päivi Naumanen, Jessie Shepherd, Frédérique van Krugten, Marleen de Mul, Kaja Staszewska, Ellen Vorstenbosch, Carlota de Miquel, Rodrigo Antunes Lima, José Luis Ayuso-Mateos, Luis Salvador-Carulla, Oriol Borrega, Carla Sabariego, Renaldo M. Bernard, Christophe Vanroelen, Jessie Gevaert, Karen Van Aerden, Alberto Raggi, Francesco Seghezzi & Josep Maria Haro
Objective: This article describes the EMPOWER study, a controlled trial aiming to determine the effectiveness and cost-effectiveness of an eHealth intervention to prevent common health problems and reduce presenteeism and absenteeism in the workplace. Intervention: The EMPOWER intervention spans universal, secondary and tertiary prevention and consists of an eHealth platform delivered via a website and a smartphone app designed to guide employees throughout different modules according to their specific profiles. Design: A stepped-wedge cluster randomized...
Data from: Labor market integration of people with disabilities: results from the Swiss Spinal Cord Injury Cohort Study
Jan D. Reinhardt, Marcel W.M. Post, Christine Fekete, Bruno Trezzini, Martin W.G. Brinkhof, Marcel W. M. Post & Martin W. G. Brinkhof
Objectives: We aimed to describe labor market participation (LMP) of persons with spinal cord injury (SCI) in Switzerland, to examine potential determinants of LMP, and to compare LMP between SCI and the general population. Methods: We analyzed data from 1458 participants of employable age from the cross-sectional community survey of the Swiss Spinal Cord Injury Cohort Study. Data on LMP of the Swiss general population were obtained from the Swiss Federal Statistics Office. Factors associated...
Wurde der Kuhreihen auf dem Alphorn gejodelt?
Andrea Kammermann & Yannick Wey210109_Palliativ TI.sav
Nicola Diviani, Marco Bernardi, Claudia Gamondi, Piercarlo Saletti, Georg Stüssi, Michel Delbue - Luisoni & Sara Rubinelli
Data were collected through a cross-sectional representative population survey (N = 313) conducted in early 2021 in the Italian-speaking part of Switzerland. The goal of the survey is to understand the knowledge and awareness of palliative care in the Italian-speaking Swiss general population, describing the main misconceptions or false beliefs and their relationship with attitudes towards palliative care.
The data can be used freely upon request to the first author: nicola.diviani@paraplegie.ch
The data can be used freely upon request to the first author: nicola.diviani@paraplegie.ch
Additional file 2 of Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang & Jinxi Zhao
Additional file 2. Publication bias.
Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang & Jinxi Zhao
Abstract Objective To evaluate the cardiovascular and renal benefits of finerenone, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagonlike peptide-1 receptor agonists (GLP-1 RA) in patients with Type 2 Diabetes Mellitus (T2DM) and chronic kidney disease (CKD) with network meta-analysis. Methods Systematic literature searches were conducted of PubMed, Cochrane Library, Web of Science, Medline and Embase covering January 1, 2000 to December 30, 2021. Randomized control trials (RCTs) comparing finerenone, SGLT-2i and GLP-1 RA in diabetics with...
Mehrstimmigkeit im Naturjodel verstärkt Emotionen
Andrea KammermannDie Kunst, einen Naturjodel zu memorieren
Raymond Ammann, Andrea Kammermann & Yannick WeyNCALD as a potential predictive biomarkerfor the efficacy of platinum-basedchemotherapy in ovarian cancer - Supplementary Figure 3
Sarah M Konrad, Kristina Schwamborn, Achim Kru¨ ger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill & Juliane Ramser
Aim: Since reliable response predictors to platinum-based chemotherapy in ovarian cancer (OC) are scarce, we characterize NCALD as a predictive biomarker. Materials & methods: NCALD mRNA (n = 100) and protein (n = 102) expression was analyzed in OC samples and associated with patient outcome. A stable OC cell line knockdown was generated and cellular response to platinum was explored. Results: High NCALD mRNA and protein expression was significantly associated with longer overall patient survival...
NCALD as a potential predictive biomarkerfor the efficacy of platinum-basedchemotherapy in ovarian cancer - Supplementary Figure 1
Sarah M Konrad, Kristina Schwamborn, Achim Kru¨ ger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill & Juliane Ramser
Aim: Since reliable response predictors to platinum-based chemotherapy in ovarian cancer (OC) are scarce, we characterize NCALD as a predictive biomarker. Materials & methods: NCALD mRNA (n = 100) and protein (n = 102) expression was analyzed in OC samples and associated with patient outcome. A stable OC cell line knockdown was generated and cellular response to platinum was explored. Results: High NCALD mRNA and protein expression was significantly associated with longer overall patient survival...
sj-docx-1-dhj-10.1177_20552076221131145 - Supplemental material for Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial design
Beatriz Olaya, Christina M. Van der Feltz-Cornelis, Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Marjo Sinokki, Päivi Naumanen, Jessie Shepherd, Frédérique van Krugten, Marleen de Mul, Kaja Staszewska, Ellen Vorstenbosch, Carlota de Miquel, Rodrigo Antunes Lima, José Luis Ayuso-Mateos, Luis Salvador-Carulla, Oriol Borrega, Carla Sabariego, Renaldo M. Bernard, Christophe Vanroelen, Jessie Gevaert, Karen Van Aerden, Alberto Raggi, Francesco Seghezzi & Josep Maria Haro
Supplemental material, sj-docx-1-dhj-10.1177_20552076221131145 for Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial design by Beatriz Olaya, Christina M. Van der Feltz-Cornelis and Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Marjo Sinokki, Päivi Naumanen, Jessie Shepherd, Frédérique van Krugten, Marleen de Mul, Kaja Staszewska, Ellen Vorstenbosch, Carlota de Miquel, Rodrigo Antunes Lima, José Luis Ayuso-Mateos, Luis Salvador-Carulla, Oriol Borrega, Carla Sabariego,...
Improving collaboration between specialists and general practitioners in services for individuals with chronic spinal cord injury living in rural areas of Switzerland: Baseline results from the SCI-Co study
Rebecca Tomaschek, Armin Gemperli & Stefan Essig
Strategies to combine primary and specialized care are crucial to meet the needs of individuals with spinal cord injury (SCI) located in rural areas. We explored the collaboration between general practitioners (GPs) and SCI specialists who will participate in an intervention study to improve their collaboration. A questionnaire survey from August to October 2020. Primary Care, Specialized SCI care. Eight GPs and 13 SCI specialists. Baseline results from the SCI-Co study. N/A. Overall, satisfaction ratings...
210109_Palliativ TI.sav
Nicola Diviani, Marco Bernardi, Claudia Gamondi, Piercarlo Saletti, Georg Stüssi, Michel Delbue - Luisoni & Sara Rubinelli
Data were collected through a cross-sectional representative population survey (N = 313) conducted in early 2021 in the Italian-speaking part of Switzerland. The goal of the survey is to understand the knowledge and awareness of palliative care in the Italian-speaking Swiss general population, describing the main misconceptions or false beliefs and their relationship with attitudes towards palliative care.
The data can be used freely upon request to the first author: nicola.diviani@paraplegie.ch
The data can be used freely upon request to the first author: nicola.diviani@paraplegie.ch
Humor in radiological breast cancer screening: a way of improving patient service?
Elisabeth Sartoretti, Thomas Sartoretti, Dow Mu Koh, Sabine Sartoretti-Schefer, Sebastian Kos, Romana Goette, Ricardo Donners, Robyn Benz, Johannes M. Froehlich, Simon Matoori, Peter Dubsky, Tino Plümecke, Rosemarie Forstner, Willibald Ruch, Matthias Meissnitzer, Klaus Hergan, Selina Largiader & Andreas Gutzeit
Abstract Background Breast cancer screening is essential in detecting breast tumors, however, the examination is stressful. In this study we analyzed whether humor enhances patient satisfaction. Methods In this prospective randomized study 226 patients undergoing routine breast cancer screening at a single center during October 2020 to July 2021 were included. One hundred thirty-two were eligible for the study. Group 1 (66 patients) received an examination with humorous intervention, group 2 (66 patients) had a...
EUROSHIP Working Paper No. 20 Summary of Outcomes of Social Indicator Workshop
MacNaughton Clara, András Gábos, István György Tóth, Federico Ciani, Mario Biggeri & Jerome Bickenbach
This is a publication in the project`s working papers` series.
External validation of EPIC’s Risk of Unplanned Readmission model, the LACE+ index and SQLape® as predictors of unplanned hospital readmissions: A monocentric, retrospective, diagnostic cohort study in Switzerland
Aljoscha Benjamin Hwang
Introduction: Readmissions after an acute care hospitalization are relatively common, costly to the health care system, and are associated with significant burden for patients. As one way to reduce costs and simultaneously improve quality of care, hospital readmissions receive increasing interest from policy makers. It is only relatively recently that strategies were developed with the specific aim of reducing unplanned readmissions using prediction models to identify patients at risk. EPIC’s Risk of Unplanned Readmission model...
sj-docx-1-dhj-10.1177_20552076221131145 - Supplemental material for Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial design
Beatriz Olaya, Christina M. Van der Feltz-Cornelis, Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Marjo Sinokki, Päivi Naumanen, Jessie Shepherd, Frédérique van Krugten, Marleen de Mul, Kaja Staszewska, Ellen Vorstenbosch, Carlota de Miquel, Rodrigo Antunes Lima, José Luis Ayuso-Mateos, Luis Salvador-Carulla, Oriol Borrega, Carla Sabariego, Renaldo M. Bernard, Christophe Vanroelen, Jessie Gevaert, Karen Van Aerden, Alberto Raggi, Francesco Seghezzi & Josep Maria Haro
Supplemental material, sj-docx-1-dhj-10.1177_20552076221131145 for Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial design by Beatriz Olaya, Christina M. Van der Feltz-Cornelis and Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Marjo Sinokki, Päivi Naumanen, Jessie Shepherd, Frédérique van Krugten, Marleen de Mul, Kaja Staszewska, Ellen Vorstenbosch, Carlota de Miquel, Rodrigo Antunes Lima, José Luis Ayuso-Mateos, Luis Salvador-Carulla, Oriol Borrega, Carla Sabariego,...
Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial design
Beatriz Olaya, Christina M. Van der Feltz-Cornelis, Leona Hakkaart-van Roijen, Dorota Merecz-Kot, Marjo Sinokki, Päivi Naumanen, Jessie Shepherd, Frédérique van Krugten, Marleen de Mul, Kaja Staszewska, Ellen Vorstenbosch, Carlota de Miquel, Rodrigo Antunes Lima, José Luis Ayuso-Mateos, Luis Salvador-Carulla, Oriol Borrega, Carla Sabariego, Renaldo M. Bernard, Christophe Vanroelen, Jessie Gevaert, Karen Van Aerden, Alberto Raggi, Francesco Seghezzi & Josep Maria Haro
Objective: This article describes the EMPOWER study, a controlled trial aiming to determine the effectiveness and cost-effectiveness of an eHealth intervention to prevent common health problems and reduce presenteeism and absenteeism in the workplace. Intervention: The EMPOWER intervention spans universal, secondary and tertiary prevention and consists of an eHealth platform delivered via a website and a smartphone app designed to guide employees throughout different modules according to their specific profiles. Design: A stepped-wedge cluster randomized...
Additional file 1 of Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang & Jinxi Zhao
Additional file 1. RoB-2 evaluation.
Impact Free Journal für freie Bildungswissenschaftler
Peter Tremp & Gabi ReinmannAffiliations
-
University of Lucerne35
-
University Medical Center Hamburg-Eppendorf8
-
Technical University of Munich8
-
Swiss Paraplegic Research8
-
Ludwig-Maximilians-Universität München8
-
Sichuan University7
-
West China Hospital of Sichuan University6
-
Binzhou Medical University6
-
Kunming Children's Hospital6
-
Xuan Wu Hospital of the Capital Medical University6